Table 5.

Comparison of clinical outcomes between diabetes patients with CVD who experienced DKA and those who experienced HHS.

Morbidity	HHS	DKA	Crude OR (95% CI)	aOR (95% CI)*
	n = 16,367	n = 62,052
In-hospital mortality	632 (3.9)	4,675 (7.5)	2.03 (1.86–2.219)	2.30 (2.11–2.51)
Acute respiratory failure	3,306 (20.2)	15,765 (25.4)	1.35 (1.29–1.40)	1.41 (1.35–1.48)
Septic shock	255 (1.6)	1,498 (2.4)	1.56 (1.37–1.79)	1.71 (1.49–1.96)
Acute kidney failure	9,853 (60.2)	37,229 (60.0)	0.99 (0.96–1.03)	1.15 (1.10–1.19)
Sepsis	2,843 (17.4)	17,398 (28.0)	1.85 (1.77–1.94)	2.00 (1.91–2.09)
Acute neurological failure	1,078 (6.6)	4,197 (6.8)	1.03 (0.96–1.10)	1.16 (1.08–1.25)
Pulmonary embolism	143 (0.9)	864 (1.4)	1.60 (1.34–1.91)	1.58 (1.32–1.89)
Deep vein thrombosis	177 (1.1)	1,012 (1.6)	1.52 (1.29–1.78)	1.52 (1.29–1.80)
Acute liver failure	149 (0.9)	1,575 (2.5)	2.83 (2.39–3.36)	2.71 (2.29–3.22)
Mechanical ventilation	1,229 (7.5)	8,223 (13.3)	1.88 (1.77–2.00)	1.91 (1.79–2.03)
Noninvasive ventilation	689 (4.2)	2,780 (4.5)	1.07 (0.98–1.16)	1.15 (1.06–1.26)

^*Model adjusted for age, race, admission type, insurance status, income quartile, patient location, hospital bed size, hospital location/teaching status, number of medical comorbidities, and admission year.